NCT05792852 Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID
| NCT ID | NCT05792852 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Disabilities Multiple |
| Study Type | INTERVENTIONAL |
| Enrollment | 21 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 21 participants in total. It began in 2023-04-01 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.
Eligibility Criteria
Inclusion Criteria: * Self-identify as disabled * Report problems with social participation * Speak English * Live in a community setting Exclusion Criteria: * Severe communication impairment limiting ability to verbally indicate interest in participation
Contact & Investigator
Joy Hammel, PhD
PRINCIPAL INVESTIGATOR
University of Illinois at Chicago
Frequently Asked Questions
Who can join the NCT05792852 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Disabilities Multiple. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05792852 currently recruiting?
Yes, NCT05792852 is actively recruiting participants. Contact the research team at hammel@uic.edu for enrollment information.
Where is the NCT05792852 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05792852 clinical trial?
NCT05792852 is sponsored by University of Illinois at Chicago. The principal investigator is Joy Hammel, PhD at University of Illinois at Chicago. The trial plans to enroll 21 participants.